Gain Therapeutics, Inc. (GANX)
1.87
+0.07
(+3.89%)
USD |
NASDAQ |
Apr 13, 16:00
1.88
+0.01
(+0.53%)
After-Hours: 20:00
Gain Therapeutics EPS Diluted (Quarterly) : -0.1132 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 1.596 |
| Agenus, Inc. | -0.301 |
| Alnylam Pharmaceuticals, Inc. | 1.368 |
| Savara, Inc. | -0.1341 |
| Arrowhead Pharmaceuticals, Inc. | 0.219 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -4.538M |
| Total Expenses (Quarterly) | 4.538M |
| Enterprise Value | 59.35M |
| Earnings Yield | -32.81% |
| Normalized Earnings Yield | -32.81 |